Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
118.72
-1.17 (-0.98%)
At close: May 29, 2026, 4:00 PM EDT
118.60
-0.12 (-0.10%)
After-hours: May 29, 2026, 7:53 PM EDT
Merck & Co. Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 65,768 | 65,011 | 64,168 | 60,115 | 59,283 | 48,704 | |
Revenue Growth (YoY) | 2.89% | 1.31% | 6.74% | 1.40% | 21.72% | 17.31% |
Cost of Revenue | 17,158 | 16,382 | 15,193 | 16,126 | 17,411 | 13,626 |
Gross Profit | 48,610 | 48,629 | 48,975 | 43,989 | 41,872 | 35,078 |
Selling, General & Admin | 10,880 | 10,733 | 10,816 | 10,504 | 10,042 | 9,634 |
Research & Development | 24,760 | 15,789 | 17,938 | 30,531 | 13,548 | 12,245 |
Other Operating Expenses | 1,015 | 889 | 309 | 599 | 337 | 661 |
Total Operating Expenses | 36,655 | 27,411 | 29,063 | 41,634 | 23,927 | 22,540 |
Operating Income | 11,955 | 21,218 | 19,912 | 2,355 | 17,945 | 12,538 |
Total Non-Operating Income (Expense) | -325 | -151 | 24 | -466 | -1,501 | 1,341 |
Pretax Income | 11,630 | 21,067 | 19,936 | 1,889 | 16,444 | 13,879 |
Provision for Income Taxes | 2,696 | 2,804 | 2,803 | 1,512 | 1,918 | 1,521 |
Net Income | 8,935 | 18,254 | 17,117 | 365 | 14,519 | 13,049 |
Minority Interest in Earnings | -1 | 9 | 16 | 12 | 7 | 13 |
Earnings From Discontinued Operations | - | - | - | - | - | 704 |
Net Income to Common | 8,935 | 18,254 | 17,117 | 365 | 14,519 | 13,049 |
Net Income Growth | -48.75% | 6.64% | 4589.59% | -97.49% | 11.27% | 84.65% |
Shares Outstanding (Basic) | 2,491 | 2,502 | 2,532 | 2,537 | 2,532 | 2,530 |
Shares Outstanding (Diluted) | 2,493 | 2,507 | 2,541 | 2,547 | 2,542 | 2,538 |
Shares Change (YoY) | -1.79% | -1.34% | -0.24% | 0.20% | 0.16% | -0.12% |
EPS (Basic) | 3.55 | 7.30 | 6.76 | 0.14 | 5.73 | 4.88 |
EPS (Diluted) | 3.55 | 7.28 | 6.74 | 0.14 | 5.71 | 4.86 |
EPS Growth | -48.33% | 8.01% | 4714.29% | -97.55% | 17.49% | 173.03% |
Shares Outstanding | 2,470 | 2,475 | 2,528 | 2,532 | 2,538 | 2,528 |
Free Cash Flow | 14,115 | 12,360 | 18,096 | 9,143 | 14,707 | 9,661 |
Free Cash Flow Growth | 14.20% | -31.70% | 97.92% | -37.83% | 52.23% | 65.88% |
Free Cash Flow Per Share | 5.66 | 4.93 | 7.12 | 3.59 | 5.79 | 3.81 |
Dividends Per Share | 3.280 | 3.240 | 3.080 | 2.920 | 2.760 | 2.600 |
Dividend Growth | 1.23% | 5.20% | 5.48% | 5.80% | 6.15% | 6.56% |
Gross Margin | 73.91% | 74.80% | 76.32% | 73.17% | 70.63% | 72.02% |
Operating Margin | 18.18% | 32.64% | 31.03% | 3.92% | 30.27% | 25.74% |
Profit Margin | 13.58% | 28.09% | 26.70% | 0.63% | 24.50% | 25.37% |
FCF Margin | 21.46% | 19.01% | 28.20% | 15.21% | 24.81% | 19.84% |
EBITDA | 18,206 | 27,056 | 24,411 | 6,227 | 21,854 | 15,752 |
EBITDA Margin | 27.68% | 41.62% | 38.04% | 10.36% | 36.86% | 32.34% |
EBIT | 11,955 | 21,218 | 19,912 | 2,355 | 17,945 | 12,538 |
EBIT Margin | 18.18% | 32.64% | 31.03% | 3.92% | 30.27% | 25.74% |
Effective Tax Rate | 23.18% | 13.31% | 14.06% | 80.04% | 11.66% | 10.96% |